Literature DB >> 1429672

Processing and secretion of tumor necrosis factor alpha in endotoxin-treated Mono Mac 6 cells are dependent on phorbol myristate acetate.

A Pradines-Figueres1, C R Raetz.   

Abstract

Lipopolysaccharide (LPS, endotoxin) is a potent stimulator of tumor necrosis factor alpha (TNF alpha) synthesis and secretion in mouse macrophage tumor cells (Golenbock, D. T., Hampton, R. Y., Qureshi, N., Takayama, K., and Raetz, C. H. R. (1991) J. Biol. Chem. 266, 19490-19498). In contrast, addition of LPS (10 ng/ml) to human monomyelocytic (Mono Mac 6) cells induces very little production of TNF alpha, as judged by immunoassay of the growth medium. When 30 ng/ml 4-beta-phorbol-12-myristate 13-acetate (PMA) is added together with LPS, large amounts of TNF alpha are secreted. PMA alone is inactive. Maximal TNF alpha levels in the medium are achieved at 1 ng/ml of LPS. Protein kinase C inhibitors, such as H7 (1-(5-isoquinolinylsulfonyl)-2-methylpiperazine), staurosporine, and sphingosine, reduce TNF alpha secretion stimulated by PMA. The effect of PMA has been investigated at each stage of TNF alpha biogenesis. Treatment of Mono Mac 6 cells with LPS alone results in rapid, transient, and full expression of TNF alpha mRNA. Concomitant addition of PMA does not increase TNF alpha mRNA synthesis any further, but it prolongs the half-life of TNF alpha mRNA about 3-fold. However, mRNA stabilization does not account for the striking effect of PMA on TNF alpha secretion. Analysis of TNF alpha synthesis and secretion by immunoprecipitation indicates that LPS alone is fully effective in stimulating the formation of the intracellular 26-kDa TNF alpha precursor. LPS alone is not sufficient to allow processing of the precursor and secretion of mature 17-kDa TNF alpha. The rate of TNF alpha secretion observed immediately after the addition of PMA to LPS-pretreated cells is similar to the maximum rate from LPS/PMA-treated cells, but without the lag observed in cells after being exposed to LPS and PMA simultaneously. In summary, PMA is required for the completion of TNF alpha precursor processing and secretion in LPS-treated human Mono Mac 6 cells, whereas murine RAW cells are able to complete the terminal steps of TNF alpha processing in the absence of PMA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429672

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Dipalmitoylphosphatidylcholine modulates inflammatory functions of monocytic cells independently of mitogen activated protein kinases.

Authors:  A Tonks; R H Morris; A J Price; A W Thomas; K P Jones; S K Jackson
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.

Authors:  R A Heller; M Schena; A Chai; D Shalon; T Bedilion; J Gilmore; D E Woolley; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 3.  Comparative advantages of mechanical biosensors.

Authors:  J L Arlett; E B Myers; M L Roukes
Journal:  Nat Nanotechnol       Date:  2011-03-27       Impact factor: 39.213

4.  Protein kinase C-alpha mediates TNF release process in RBL-2H3 mast cells.

Authors:  Ihab T Abdel-Raheem; Izumi Hide; Yuhki Yanase; Yukari Shigemoto-Mogami; Norio Sakai; Yasuhito Shirai; Naoaki Saito; Farid M Hamada; Nagh A El-Mahdy; Alaa El-Din E Elsisy; Samya S Sokar; Yoshihiro Nakata
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

5.  Chaperone-like properties of the prodomain of TNFalpha-converting enzyme (TACE) and the functional role of its cysteine switch.

Authors:  Jennifer D Leonard; Frank Lin; Marcos E Milla
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

6.  Biology of TACE inhibition.

Authors:  R C Newton; K A Solomon; M B Covington; C P Decicco; P J Haley; S M Friedman; K Vaddi
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

7.  A monoclonal antibody that recognizes phosphatidylinositol inhibits induction of tumor necrosis factor alpha by different strains of Plasmodium falciparum.

Authors:  C A Bate; D Kwiatkowski
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Inhibitory immunoglobulin M antibodies to tumor necrosis factor-inducing toxins in patients with malaria.

Authors:  C A Bate; D Kwiatkowski
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency.

Authors:  P S Cohen; H Nakshatri; J Dennis; T Caragine; M Bianchi; A Cerami; K J Tracey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation.

Authors:  Sushila K Nordone; Glicerio A Ignacio; Lishan Su; Gregory D Sempowski; Douglas T Golenbock; Liwu Li; Gregg A Dean
Journal:  AIDS Res Hum Retroviruses       Date:  2007-11       Impact factor: 2.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.